[ad_1]
The filing was made Monday by New York, 48 other states, Washington, DC and various other territories against Purdue Pharma and other distributors and manufacturers, according to the New York attorney general. A financial breakdown by state provided in the court record shows New York is seeking to claim $ 165 billion.
An official with knowledge of the case acknowledges that it is unlikely that anyone will recover this large amount.
Purdue has repeatedly denied any wrongdoing and said in response to the filing that the claims were expected.
“On July 30, Purdue successfully concluded one of the largest observation campaigns in Chapter 11 history,” Michele Sharp, executive director of media relations for Purdue Pharma, said in a statement. “Purdue is continuing its efforts to emerge from bankruptcy, gain additional support for the proposed settlement and implement a final resolution.” The proposed settlement would bring more than $ 10 billion in value, including 100% of Purdue’s assets, to claimants and communities. fight the opioid crisis by providing the necessary funds, as well as millions of doses of life-saving opioid dependence treatment and anti-overdose drugs. “
As part of the filing, states cited data on opioid deaths from the United States Centers for Disease Control and Prevention from 1999 to 2018. New York City recorded 3,050 deaths in 2018. Death figures have adjusted to reflect a CDC formula due to various reasons for underreported opioid deaths according to the official.
New York’s lawsuit against all opioid manufacturers and distributors was scheduled to begin in April, but has been postponed due to the coronavirus. Purdue was previously a defendant in the lawsuit, but because she filed for bankruptcy, the claim was transferred to bankruptcy court.
Oklahoma is not included in the $ 2.15 trillion claim due to its previous settlement with multiple companies.
[ad_2]
Source link